James Capretta

In the office where America decides what to do about Medicare, the loudest voice is usually the one with the cleanest math. For more than thirty years, that voice has often belonged to James C. Capretta.

Today he holds the Milton Friedman Chair at the American Enterprise Institute, a perch named for the economist whose ideas run through everything Capretta argues. His subject is narrow and enormous at the same time: health care, entitlement programs, and the long fiscal arc of the federal budget. The current preoccupation is the math that keeps getting worse. Combined federal spending on Medicare and Medicaid was equal to 1.7 percent of gross domestic product in 1980. The Congressional Budget Office projects it will reach 6.3 percent in 2026 and 7.3 percent a decade later. Capretta treats those numbers not as background noise but as the central plot.

His recent work reads like a field manual for the next deficit fight. When Congress drifts away from spending discipline, he writes that Medicare should be treated as a major cause of fiscal pressure, not exempted from it. When the 2025 reconciliation bill closed the congressional window on big savings, he turned to the executive branch and argued for refocusing the Center for Medicare and Medicaid Innovation on deep cost reductions. And when CMS announced plans to use artificial intelligence to police fee-for-service payments, he saw the first credible chance for the government to stop wasteful spending before it happens rather than chasing it afterward.

"Private incentive systems sustain themselves far longer and require less monitoring than government-run reforms."

That sentence is the whole argument in miniature. Capretta is not a man who wants to abolish the safety net. He wants to build a better set of rules around the choices people already make - rules that reward higher-value, lower-cost care without a central authority dictating every transaction. It is a market-oriented position, delivered without slogans, defended with footnotes.

Here is a detail that explains the man. Capretta arrived at the White House Office of Management and Budget twice. The first time, he was a budget examiner - the kind of staffer who reads the agency line items nobody else wants to read. The second time, two decades of work later, he came back as an associate director and a presidential appointee, the lead OMB official for every aspect of Medicare and Medicaid reform from 2001 to 2004, plus Social Security, welfare, labor, and education.

The path between those two visits ran through the rooms where federal health spending is actually decided. He spent roughly a decade in Congress as a senior analyst on health care and Social Security, first at the US House Committee on Ways and Means, then at the US Senate Budget Committee. He learned the policy from the inside of the legislative machine and then from the inside of the executive one. Few analysts have sat in that many seats.

His training did not start in medicine or even economics. He took a BA in government from the University of Notre Dame and an MA in public policy from Duke. He came to health care through the budget, which may be why he talks about it the way he does - less as a clinical question than as a question of incentives, trade-offs, and who ultimately pays for the promises.

After leaving government in 2004 he spent two years as a managing director at Wexler and Walker Public Policy Associates, then a decade as a fellow and senior fellow at the Ethics and Public Policy Center. Since 2011 he has sat on the advisory board of the National Institute for Health Care Management Foundation. The destinations change; the subject never does.

His brief at AEI now stretches beyond the United States. Alongside Medicare, Medicaid, and the federal budget, he studies global trends in aging, health, and retirement programs - the same arithmetic problem playing out across the advanced economies, where promises made decades ago are colliding with the demographics of longer lives and smaller workforces. As a senior adviser to the Bipartisan Policy Center, he keeps a foot in the part of Washington still willing to negotiate across the aisle on exactly these questions. The throughline, from a first job reading line items to a chair named for Milton Friedman, is a refusal to let the hard numbers go unspoken.

In 2022 the AEI Press published US Health Policy and Market Reforms: An Introduction. The title is modest on purpose. Capretta set out to do something most policy books skip - lay out the major features of US health care plainly, then sketch the reforms needed to impose discipline on costs without crushing quality or innovation.

The central theme runs against the grain of both parties. Rather than expanding government control or leaving the system entirely to chance, Capretta argues for building a regulatory structure around the choices available to consumers, so they can find higher-value and lower-cost options for the services they actually need. It is a framework, not a manifesto - which is exactly why it gets used as a reference rather than read once and shelved.

His written output extends well past the book. He has authored peer-reviewed work for the Milbank Quarterly, including a study of Washington State's quasi-public insurance option, and he writes regularly for The New Atlantis and a steady run of AEI op-eds and reports. The same logic shows up everywhere: start from the numbers, respect the trade-offs, and trust incentives over mandates.

He is also a frequent guest in the long-form interview format, walking through the mechanics of reducing health care spending and chasing universal coverage without pretending either is simple. The work is consistent across formats - patient, granular, and allergic to the easy answer.